# A Polypill for Acute Coronary Syndrome

Study · id `cardio:ct-nct07032389` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07032389](<https://clinicaltrials.gov/study/NCT07032389>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07032389

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT07032389. Randomized; no masking; primary purpose treatment. Start 2025-12-05 (actual); primary completion 2030-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT07032389, source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)
- Started: 2025-12-05 (actual) (ClinicalTrials.gov record NCT07032389, source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)
- Primary completion: 2030-06-01 (anticipated) (ClinicalTrials.gov record NCT07032389, source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)
- Completion: 2030-07-31 (anticipated) (ClinicalTrials.gov record NCT07032389, source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07032389, source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07032389-2026-09-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Polypill for Acute Coronary Syndrome
- Acronym: PolyACS
- Condition: Acute Coronary Syndrome
- Intervention (Combination product): Polypill
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 2c5068bcab5ae41145cc725c9811b1f9ffa6fd94631654ad7da2f0b650d91414
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
